Compare MRVI & IBEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MRVI | IBEX |
|---|---|---|
| Founded | 2014 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 449.6M | 386.9M |
| IPO Year | 2020 | 2020 |
| Metric | MRVI | IBEX |
|---|---|---|
| Price | $3.20 | $38.25 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 3 |
| Target Price | $4.57 | ★ $31.33 |
| AVG Volume (30 Days) | ★ 1.2M | 87.8K |
| Earning Date | 11-06-2025 | 02-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 46.76 |
| EPS | N/A | ★ 2.77 |
| Revenue | $192,435,000.00 | ★ $579,735,000.00 |
| Revenue This Year | N/A | $12.15 |
| Revenue Next Year | $9.04 | $5.68 |
| P/E Ratio | ★ N/A | $13.92 |
| Revenue Growth | N/A | ★ 12.86 |
| 52 Week Low | $1.67 | $20.18 |
| 52 Week High | $6.21 | $42.99 |
| Indicator | MRVI | IBEX |
|---|---|---|
| Relative Strength Index (RSI) | 41.04 | 56.99 |
| Support Level | $3.21 | $38.20 |
| Resistance Level | $3.37 | $39.49 |
| Average True Range (ATR) | 0.16 | 0.94 |
| MACD | -0.05 | 0.07 |
| Stochastic Oscillator | 5.95 | 60.06 |
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
IBEX Ltd delivers innovative business process outsourcing (BPO), smart digital marketing, online acquisition technology, and end-to-end customer engagement solutions to help companies acquire, engage, and retain valuable customers. It is an end-to-end provider of technology-enabled customer lifecycle experience (CLX) solutions to optimize customer acquisition, engagement, expansion, and experience for its clients. IBEX operates through the Business process outsourcing segment. Its services cover three areas: Digital and omni-channel Customer Experience (ibex Connect), Digital Marketing and E-Commerce (ibex Digital) and Digital CX surveys and analytics (ibex CX). It caters to a broad range of industries, such as telecommunications, cable, financial services, and healthcare.